Synovus Financial Corp Bristol Myers Squibb CO Transaction History

Synovus Financial Corp

$8.56 Billion
Q3 2024

A detailed history of Synovus Financial Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Synovus Financial Corp holds 260,181 shares of BMY stock, worth $15 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

260,181

Previous 260,181 -0.0%

Holding current value

$15 Million

Previous $13.5 Million -0.0%

% of portfolio

0.16%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $32,600 - $42,538	822 Added 0.32%	260,181 $13.5 Million
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $302,559 - $398,325	-7,517 Reduced 2.82%	259,359 $10.8 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $3.29 Million - $3.73 Million	-68,497 Reduced 20.42%	266,876 $14.5 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $183,221 - $204,870	3,165 Added 0.95%	335,373 $19.5 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $241,588 - $268,246	3,792 Added 1.15%	332,208 $21.2 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $1.54 Million - $1.75 Million	-23,450 Reduced 6.66%	328,416 $22.8 Million
Q4 2022 Feb 06, 2023	BUY	$68.48 - $81.09 $2.35 Million - $2.78 Million	34,246 Added 10.78%	351,866 $25.3 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $1,004 - $593,973	7,730 Added 2.49%	317,620 $22.6 Million
Q2 2022 Aug 10, 2022	BUY	$72.62 - $79.98 $2.12 Million - $2.33 Million	29,161 Added 10.39%	309,890 $23.9 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $1.11 Million - $1.34 Million	-18,127 Reduced 6.07%	280,729 $20.5 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.43 Million - $1.66 Million	-26,614 Reduced 8.18%	298,856 $18.6 Million
Q3 2021 Nov 08, 2021	BUY	$59.17 - $69.31 $3.06 Million - $3.59 Million	51,797 Added 18.93%	325,470 $19.3 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $129,763 - $141,312	2,096 Added 0.77%	273,673 $18.3 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $552,811 - $621,749	9,316 Added 3.55%	271,577 $17.1 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $500,086 - $566,689	8,661 Added 3.42%	262,261 $16.3 Million
Q3 2020 Nov 09, 2020	SELL	$57.43 - $63.64 $263,718 - $292,234	-4,592 Reduced 1.78%	253,600 $15.3 Million
Q2 2020 Aug 10, 2020	SELL	$54.82 - $64.09 $3.64 Million - $4.26 Million	-66,417 Reduced 20.46%	258,192 $15.2 Million
Q1 2020 Apr 24, 2020	BUY	$46.4 - $67.43 $3.84 Million - $5.57 Million	82,666 Added 34.17%	324,609 $18.1 Million
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $1.04 Million - $1.36 Million	21,158 Added 9.58%	241,943 $15.5 Million
Q3 2019 Nov 01, 2019	BUY	$42.77 - $50.71 $619,309 - $734,280	14,480 Added 7.02%	220,785 $11.2 Million
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $634,719 - $701,861	14,225 Added 7.41%	206,305 $9.37 Million
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $2.49 Million - $2.97 Million	55,271 Added 40.4%	192,080 $9.18 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $367,991 - $477,196	-7,547 Reduced 5.23%	136,809 $7.11 Million
Q3 2018 Nov 01, 2018	BUY	$55.19 - $62.25 $57,894 - $65,300	1,049 Added 0.73%	144,356 $8.96 Million
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $182,665 - $227,672	-3,615 Reduced 2.46%	143,307 $7.94 Million
Q1 2018 May 07, 2018	SELL	$59.92 - $68.98 $525,198 - $604,609	-8,765 Reduced 5.63%	146,922 $9.29 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $658,440 - $717,869	-10,985 Reduced 6.59%	155,687 $9.54 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $9.21 Million - $10.6 Million	166,672	166,672 $10.6 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Account

Synovus Financial Corp Bristol Myers Squibb CO Transaction History